CD274 and squamous cell carcinoma: Most patients had squamous cell carcinoma (28/30, 93.3%), FIGO stage IIA2 (19/30, 63.3%), and PD-L1-positive (combined positive scores [CPS] ≥1; 29/30, 96.7%).